GSK plc Stock News & Forecasts (Dec. 15, 2025): FDA Catalyst for Depemokimab, EU Backs Nucala and Arexvy, Analysts Map the Path Ahead

GSK plc Stock News & Forecasts (Dec. 15, 2025): FDA Catalyst for Depemokimab, EU Backs Nucala and Arexvy, Analysts Map the Path Ahead

GSK plc Stock News & Forecasts (Dec. 15, 2025): FDA Catalyst for Depemokimab, EU Backs Nucala and Arexvy, Analysts Map the Path Ahead GSK plc stock (LSE: GSK, NYSE: GSK) is ending 2025 with a rare “cluster” of market-moving catalysts packed into the same two-week window: fresh U.S. regulatory momentum for a new antibiotic, European regulatory backing for multiple respiratory products, and an imminent FDA decision that could reshape GSK’s long-term outlook in severe asthma and nasal polyps. For investors, this isn’t just headline noise. It’s the kind of sequencing—approval decisions, label expansions, and portfolio reinforcement—that can change how analysts
GMR Airports Share Price Today (15 Dec 2025): GMRAIRPORT Near 52-Week High as Volume Picks Up — Latest News, Broker Targets, and What to Watch

GMR Airports Share Price Today (15 Dec 2025): GMRAIRPORT Near 52-Week High as Volume Picks Up — Latest News, Broker Targets, and What to Watch

Dec 15, 2025 — GMR Airports Ltd (NSE: GMRAIRPORT, BSE: 532754) is back in the market’s “busy runway” lane. The stock traded around the ₹105–₹106 zone on Monday, staying within striking distance of its 52-week high near ₹110.36—a level many traders now treat as the next big technical hurdle. Moneycontrol+2Trendlyne.com+2 But today’s story isn’t just price action. Investors are weighing a mix of traffic trends, tariff-driven earnings momentum at Delhi, a growing push into non-aero adjacencies (duty free, cargo, parking, real estate), and fresh focus on refinancing after reports that the company is preparing a long-tenor bond issue. investor.gmraero.com+2Business Standard+2
ICICI Bank stock today (15 Dec 2025): ICICIBANK holds near ₹1,366 as ICICI Prudential AMC IPO draws strong demand; what analysts forecast next

ICICI Bank stock today (15 Dec 2025): ICICIBANK holds near ₹1,366 as ICICI Prudential AMC IPO draws strong demand; what analysts forecast next

ICICI Bank Limited (NSE: ICICIBANK, BSE: 532174, NYSE ADR: IBN) is trading in a cautious Indian market on December 15, 2025, with the stock hovering around ₹1,366 in early-to-mid session ranges even as broader sentiment stays fragile on foreign outflows and a record-low rupee. Moneycontrol+2Reuters+2 What’s putting ICICI Bank back on investors’ radar today isn’t just the macro mood—it’s the high-profile IPO of ICICI Prudential Asset Management (ICICI AMC), where demand is coming in strongly, plus fresh disclosures around ICICI Bank’s majority stake and a Citi-hosted investor interaction scheduled for today. Reuters+2SEC+2 ICICI Bank share price check: where the stock
Indian Oil Corporation (IOC) Share Price Today, Dec 15, 2025: Interim Dividend, Refining Margins, Russian Crude Risks and Analyst Targets

Indian Oil Corporation (IOC) Share Price Today, Dec 15, 2025: Interim Dividend, Refining Margins, Russian Crude Risks and Analyst Targets

New Delhi — December 15, 2025 Indian Oil Corporation Ltd. (IOCL) stock (NSE: IOC; BSE: 530965) is back in the spotlight heading into the second half of December, with traders and long-term investors weighing a fresh interim dividend, a stronger recent earnings backdrop, and a geopolitics-heavy crude procurement environment. By early afternoon on Monday, Indian Oil shares were trading around ₹166.60, up about 1.8% on the day, even as broader Indian equities slipped amid foreign outflows and trade-deal uncertainty. The Economic Times+1 Indian Oil share price today: IOC stock outperforms as the market turns cautious The broader tone in Indian
Corona Remedies Share Price Today (15 Dec 2025): Pharma Stock Debuts at 38% Premium After ₹655-Crore IPO — Latest News, Forecasts, Valuation and Analyst Views

Corona Remedies Share Price Today (15 Dec 2025): Pharma Stock Debuts at 38% Premium After ₹655-Crore IPO — Latest News, Forecasts, Valuation and Analyst Views

New Delhi / Mumbai, December 15, 2025 — Corona Remedies Limited, the Ahmedabad-headquartered branded pharmaceutical formulations company (not the beer), hit Dalal Street with a headline-worthy debut on Monday: the stock listed at a 38%+ premium to its IPO price, quickly becoming one of the most-watched new names in India’s healthcare space. Business Standard+2Moneycontrol+2 Below is a consolidated, publication-ready roundup of today’s key developments (15.12.2025) — including the latest price action, what the grey market had predicted, and how brokerages and IPO research notes are framing Corona Remedies’ valuation and outlook. Corona Remedies stock news today: listing pop, intraday surge
Reliance Industries Share Price Today (15 December 2025): What’s Driving RIL Stock, Latest News, and Analyst Targets

Reliance Industries Share Price Today (15 December 2025): What’s Driving RIL Stock, Latest News, and Analyst Targets

Reliance Industries Limited (RIL) shares were trading largely steady on Monday, 15 December 2025, hovering around the ₹1,55x zone and staying within striking distance of their recent 52-week high as investors weighed a busy mix of catalysts—fresh FMCG acquisition chatter, a recent S&P credit-rating upgrade, developments around Jio’s IPO runway, and a sanctions-driven reshuffle in the group’s crude sourcing and export calculus. Business Standard+1 The near-flat action in RIL stock also mirrored a cautious broader tape: Indian equities opened softer amid ongoing foreign outflows and rupee weakness, keeping stock-specific positives from turning into a clean breakout day. Reuters Reliance Industries
BSE Ltd Share Price Today (15 December 2025): Stock Slips With Market, but New Growth Catalysts Keep BSE in Focus

BSE Ltd Share Price Today (15 December 2025): Stock Slips With Market, but New Growth Catalysts Keep BSE in Focus

Mumbai | December 15, 2025 — BSE Ltd (Bombay Stock Exchange’s listed entity) is back on traders’ and long-term investors’ radars, even on a down day for Indian equities. The stock was trading at ₹2,685.70 around midday, down 1.80% on the session, with a market cap of about ₹1.09 lakh crore and a 52-week range of ₹1,227.32–₹3,030.00. Business Standard That intraday softness isn’t happening in a vacuum. Indian benchmarks were lower on foreign outflows and renewed uncertainty around a U.S.–India trade deal, while the rupee hit fresh record lows — a macro cocktail that tends to reduce risk appetite across
Hindustan Zinc Share Price Today: Stock Hits Fresh 52-Week High as Jefferies Initiates Coverage With ‘Buy’ — News, Targets, and Outlook (Dec 15, 2025)

Hindustan Zinc Share Price Today: Stock Hits Fresh 52-Week High as Jefferies Initiates Coverage With ‘Buy’ — News, Targets, and Outlook (Dec 15, 2025)

Hindustan Zinc Limited (NSE: HINDZINC) is back in the spotlight on December 15, 2025, after the stock climbed to a fresh 52-week high amid a roaring silver rally and a new bullish call from Jefferies. The metal producer’s shares traded in a wide band during the session—touching ₹571.80 at the high and ₹555.75 at the low—before ending the day at ₹560.95, according to Yahoo Finance historical data. Yahoo Finance Today’s market conversation has a simple theme: Hindustan Zinc is increasingly being treated as a “silver + low-cost zinc” story, and brokerage notes are now framing it less like a conventional
Transformers and Rectifiers (India) Ltd (TARIL) Stock Surges on Order-Book Optimism: Latest News, Forecasts and Key Levels (15 Dec 2025)

Transformers and Rectifiers (India) Ltd (TARIL) Stock Surges on Order-Book Optimism: Latest News, Forecasts and Key Levels (15 Dec 2025)

New Delhi/Mumbai — December 15, 2025: Transformers and Rectifiers (India) Limited (NSE: TARIL, BSE: 532928) is back on traders’ radar after a sharp rebound from last week’s 52-week low, powered by heavy volumes, fresh order momentum headlines, and management commentary that the company expects to close the year with a much larger order book. On Monday, TARIL shares rose as much as ~11% intraday to around ₹312, extending gains for a second straight session and taking the two-day rally to roughly 30% from the recent trough. The Economic Times+1 This bounce comes after a bruising slide that dragged the stock
NHAI Revises Meghalaya Toll Collection to ₹96.05 Crore for FY 2024–25 After RTI Flags Discrepancy

NHAI Revises Meghalaya Toll Collection to ₹96.05 Crore for FY 2024–25 After RTI Flags Discrepancy

Shillong, December 15, 2025 — The National Highways Authority of India (NHAI) has issued revised toll revenue figures for Meghalaya, confirming that ₹96.05 crore was collected during FY 2024–25 across the state’s toll plazas—an update that followed a Right to Information (RTI) query and an ensuing dispute over the accuracy of earlier data. NorthEast Now+2The Shillong Times+2 The correction has become a flashpoint for a wider debate on transparency in toll accounting, as well as the long-running complaint that Meghalaya continues to collect tolls while lacking Wayside Amenities (WSAs)—the rest facilities commuters expect on busy national highways. NorthEast Now+2EastMojo+2 What
15 December 2025
InterGlobe Aviation Ltd Stock (IndiGo) Today: Share Price Rebounds as DGCA Scrutiny, Pilot Rules and Broker Targets Shape the Outlook (15 December 2025)

InterGlobe Aviation Ltd Stock (IndiGo) Today: Share Price Rebounds as DGCA Scrutiny, Pilot Rules and Broker Targets Shape the Outlook (15 December 2025)

InterGlobe Aviation Ltd (NSE: INDIGO, BSE: 539448) is back in the spotlight on 15 December 2025, with investors trying to price two stories at once: a powerful long-term growth runway in Indian aviation — and a very real near-term operational and regulatory storm around IndiGo. As of 12:19 pm IST on 15 December, InterGlobe Aviation was quoted around ₹4,960.50, up about 2.06% on the day, after a bruising stretch of volatility earlier this month. The day’s trading range was roughly ₹4,864.50–₹5,014.00, while the 52-week range sits near ₹3,945.00–₹6,232.50. Moneycontrol That bounce, however, is happening in the middle of a fast-moving
India Stock Market Today (Dec 15, 2025): Sensex, Nifty Slip as FII Outflows Persist; Rupee Hits Fresh Record Low — Key Takeaways, Stocks to Watch, and Nifty Levels

India Stock Market Today (Dec 15, 2025): Sensex, Nifty Slip as FII Outflows Persist; Rupee Hits Fresh Record Low — Key Takeaways, Stocks to Watch, and Nifty Levels

Indian equities started the week on a cautious note on Monday, December 15, 2025, with benchmark indices ending lower after a volatile session that saw early losses pare back intraday. Persistent foreign portfolio outflows, lingering uncertainty around a potential U.S.–India trade deal, and fresh pressure on the rupee kept risk appetite in check across Dalal Street. Reuters+1 By the close, the Nifty 50 fell 0.51% to 25,913.45, while the BSE Sensex slipped 0.46% to 84,875.85. The weakness was broad-based, with all 16 major sectoral indices in the red and mid- and small-caps also lower. Reuters Sensex and Nifty performance: A

Stock Market Today

Anglo American share price slips as BofA turns neutral after copper outlook cut

Anglo American share price slips as BofA turns neutral after copper outlook cut

7 February 2026
Anglo American shares closed down 0.75% at 3,435 pence Friday after BofA Global Research downgraded the miner to “neutral” and raised its price target to 3,600 pence. Anglo cut its 2026 copper production guidance and warned of continued weakness at De Beers. The company expects $200 million in charges tied to its Chile copper operations in the second half of 2025.
Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

7 February 2026
Amazon shares fell Friday after the company announced a $200 billion AI infrastructure plan for 2026, exceeding analyst expectations and reviving investor concerns about profitability. Combined 2026 capex flagged by Amazon, Alphabet, Microsoft, and Meta now tops $630 billion. Nvidia, AMD, and Broadcom shares surged on the news, while software and data firms remained under pressure.
Go toTop